Mieko Tokano

Saitama Medical University
Country flagJapan

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (17)

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Candidemia, linked to high mortality rates, requires prompt antifungal therapy for better outcomes. Treatment is structured as an action bundle, which is beneficial when followed closely. However, the Japanese action bundle lacks detailed guidance on severe complications like endocarditis or ocular issues. To address this, we adjusted the action bundle and assessed outcomes with and without AFT intervention. We strengthened protocols for blood cultures and organ assessments, and the AFT contacted the primary physician when yeast-like fungi were detected in the patient’s blood culture bottles. Analyzing 204 candidemia cases from 2008–2021, we observed increased adherence and reduced mortality post-AFT intervention. Ophthalmology consultations rose significantly, but many patients had only one visit, suggesting inadequate follow-up. If endophthalmitis is diagnosed, a change in the treatment approach may be necessary. There is a possibility that abnormal ocular findings will be detected during subsequent visits, which highlights the need for improvement in ophthalmology follow-up rates as a future challenge for our AFT activities.

Year:

2024

Year:

2024

Vancomycin-resistant enterococci (VRE) are a significant cause of healthcare-associated infections. In Japan, the estimated isolation rate of VRE is approximately 0.2%; however, sporadic outbreaks continue to occur in healthcare facilities. Despite sporadic cases of VRE at our hospital since the 2007 outbreak, it is unclear whether the same strains from 2007 were still prevalent. Therefore, we performed whole-genome sequencing of stored VRE strains at our hospital and assessed their potential utility as an alternative to pulsed-field gel electrophoresis (PFGE) for infection control. In contrast to previous studies, our analysis focused on examining strain characteristics over time. The results of taxonomic characterization using average nucleotide identity (ANI) values and multilocus sequence typing (MLST) showed good agreement with the PFGE analysis, indicating that ANI values and MLST were viable potential alternatives to PFGE. Notably, many of the strains isolated in 2010 belonged to ST1421. The first reported VRE outbreak in Japan, caused by pstS -null VRE ST1421, occurred in Aomori in 2018. However, the present study demonstrated, for the first time, that the ST1421 strain existed in Japan as early as 2010. In the time series analysis, the observed PFGE pattern did not correlate with the time of strain isolation, particularly for isolates collected after 2012. We also observed cases where isolates sharing the same Tn1546 variant were found on distinct clonal backgrounds. While ANI and MLST may serve as suitable alternatives to PFGE for short-term outbreak evaluations, a plasmid analysis may prove useful for long-term assessments. IMPORTANCE Our study emphasizes the efficacy of whole-genome sequencing (WGS) in addressing outbreaks of vancomycin-resistant enterococci. WGS enables the identification and tracking of resistant bacterial strains, early detection and management of novel infectious disease outbreaks, and the appropriate selection and use of antibiotics. Furthermore, our approach deepens our understanding of how resistant bacteria transfer genes and adapt to their environments or hosts. For modern medicine, these insights have significant implications for controlling infections and effectively managing antibiotic use in the current era, where antibiotic resistance is progressing.

Year:

2024

Peptide p176-190, derived from the SARS-CoV-2 spike protein, is one of the major T cell epitopes that elicits the HLA-DR-restricted IL-8 response of human CD4+ T cells. Using PBMCs from a healthy individual primed with an S-protein-based SARS-CoV-2 vaccine, we established a CD4+ T cell line (TM45) and cloned T cells (TM45.2) specific for the peptide. We showed that (i) co-incubation with kynurenine leads to increased IL-8; (ii) T cells incubated in the absence of kynurenine recovered the original levels of cytokine production; and (iii) peptide p176-190 substituted at 176 Leucine for neutral hydrophilic serine completely abolished the cytokine responses of TM45.2 cells, thereby suggesting that 176 L is the first anchor residue for binding to HLA-DR. These observations collectively indicate that (i) enhanced IL-8 responses can be induced by kynurenine, which is produced under infectious conditions in COVID-19; (ii) the response is not a permanent change in the T cell phenotype; and (iii) IL-8 responses associated with harmful neutrophil extracellular traps can be abrogated by a single amino acid substitution of the viral antigens. These findings may shed light on a novel strategy for designing vaccines for viral infections that are accompanied by increased kynurenine production.

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (3)

Sho Matsushita

Saitama Medical University

JAPAN
View details

Norihito Tarumoto

Saitama Medical University

JAPAN
View details

Akihiro Yoshitake

Saitama Medical University

JAPAN
View details